Israel - Inggris - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - ertugliflozin (l-pga); sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 100 mg; ertugliflozin (l-pga) 5 mg - sitagliptin and ertugliflozin - steglujan is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• when metformin and/or a sulphonylurea (su) and one of the monocomponents of steglujan do not provide adequate glycaemic control• in patients already being treated with the combination of ertugliflozin and sitagliptin as separate tablets.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - levonorgestrel ethinylestradiol - coated tablets - 250/50mcg microgram

Israel - Inggris - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 2 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia, other acute psycoses.

Israel - Inggris - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 25 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia. other acute psychoses.

Israel - Inggris - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 10 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia .other acute psychoses.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

celltech pharmaceuticals, inc. - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - tablet - 500 ug - mykrox tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets have not been evaluated for the treatment of congestive heart failure or fluid retention due to renal or hepatic disease and the correct dosage for these conditions and other edema states has not been established. since a safe and effective diuretic dose has not been established, mykrox tablets should not be used when diuresis is desired. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia (see precautions). edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. mykrox is not indicated for the treatment of edema in pregnancy. dependent edema in pregnancy resulting

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - lisinopril - tablets - 2.5mg milligram

Israel - Inggris - Ministry of Health

megapharm ltd - flecainide acetate - tablets - flecainide acetate 50 mg - flecainide - flecainide - serious sustained life threatening supraventricular arrhythmias that have not responded to other drugs. paroxysmal atrial fibrillation and atrial flutter

Israel - Inggris - Ministry of Health

megapharm ltd - flecainide acetate - tablets - flecainide acetate 100 mg - flecainide - flecainide - serious sustained life threatening ventricular arrhytmias that have not responsed to other drugs. paroxymal atrial flutter.

Israel - Inggris - Ministry of Health

biotis ltd - terazosin as monohydrachloride dihydrate - tablets - terazosin as monohydrachloride dihydrate 5 mg - terazosin - terazosin - for symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (bph). for mild to moderate hypertension.